Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_assertion description "[The majority of papillomas in control mice regressed after termination of 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment, whereas p53m papillomas progressed to carcinomas and metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_assertion evidence source_evidence_literature NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_assertion SIO_000772 9671312 NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_assertion wasDerivedFrom befree-20140225 NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_assertion wasGeneratedBy ECO_0000203 NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.
- befree-20140225 importedOn "2014-02-25" NP607619.RAsNbnpcsLj0Scs5KkwWdsLk-KD0C6KS1W4rqcTigRQ6k130_provenance.